Protocol Specific Research Support

$35,239P30FY2013CANIH

Virginia Commonwealth University, Richmond VA

Investigators

Linked publications & trials

Paper 39574605 Paper 39554866 Paper 39417215 Paper 39415933 Paper 39415072 Paper 39379134 Paper 39345623 Paper 39345509 Paper 39314417 Paper 39303845 Paper 39302104 Paper 39293568 Paper 39279661 Paper 39277599 Paper 39269177 Paper 39263826 Paper 39185537 Paper 39156950 Paper 39074146 Paper 39005390 Paper 38979255 Paper 38978567 Paper 38959068 Paper 38925249 Paper 38909784 Paper 38903113 Paper 38895230 Paper 38883782 Paper 38775127 Paper 38750629 Paper 38743566 Paper 38719150 Paper 38712133 Paper 38712089 Paper 38710716 Paper 38701848 Paper 38675783 Paper 38660786 Paper 38656405 Paper 38645097 Paper 38619425 Paper 38591114 Paper 38575599 Paper 38556709 Paper 38554889 Paper 38534917 Paper 38522633 Paper 38503142 Paper 38468295 Paper 38457001 Paper 38436552 Paper 38400526 Paper 38396145 Paper 38381001 Paper 38352859 Paper 38323290 Paper 38303720 Paper 38273376 Paper 38272911 Paper 38226948 Paper 38214087 Paper 38206848 Paper 38199050 Paper 38196575 Paper 38179979 Paper 38117861 Paper 38081412 Paper 38061410 Paper 38051103 Paper 37986783 Paper 37961224 Paper 37949862 Paper 37935566 Paper 37922327 Paper 37918853 Paper 37890547 Paper 37869728 Paper 37863487 Paper 37852935 Paper 37839633 Paper 37823198 Paper 37804534 Paper 37777094 Paper 37768040 Paper 37766963 Paper 37739987 Paper 37739805 Paper 37722058 Paper 37699115 Paper 37686559 Paper 37675229 Paper 37659346 Paper 37649594 Paper 37625139 Paper 37602413 Paper 37569461 Paper 37552759 Paper 37537225 Paper 37508550 Paper 37502970

Abstract

The Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) places a high priority on translating the research that arises from each of its programs into pilot and Phase I clinical trials. Recent positive actions to formalize and accelerate translation of pre-clinical science have resulted in an increase in the number of early phase clinical investigator-initiated clinical trials developed at MCC. Support for these trials is available through three Clinical Research Nurses and two Data Managers, each of whom has experience in early phase trials. Solicited concepts from the MCC membership are prioritized by a committee composed of senior leaders and clinical trial experts. Concepts identified by this process are considered

View original record on NIH RePORTER →